83 related articles for article (PubMed ID: 23376546)
1. Gender and strain contributions to the variability of buprenorphine-related respiratory toxicity in mice.
Alhaddad H; Cisternino S; Saubamea B; Schlatter J; Chiadmi F; Risède P; Smirnova M; Cochois-Guégan V; Tournier N; Baud FJ; Mégarbane B
Toxicology; 2013 Mar; 305():99-108. PubMed ID: 23376546
[TBL] [Abstract][Full Text] [Related]
2. Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice.
Alhaddad H; Cisternino S; Declèves X; Tournier N; Schlatter J; Chiadmi F; Risède P; Smirnova M; Besengez C; Scherrmann JM; Baud FJ; Mégarbane B
Crit Care Med; 2012 Dec; 40(12):3215-23. PubMed ID: 22975888
[TBL] [Abstract][Full Text] [Related]
3. Editor's Highlight: Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat.
Cohier C; Chevillard L; Salle S; Risède P; Roussel O; Mégarbane B
Toxicol Sci; 2017 Feb; 155(2):389-399. PubMed ID: 27803387
[TBL] [Abstract][Full Text] [Related]
4. Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats.
Cohier C; Chevillard L; Risède P; Roussel O; Mégarbane B
Toxicol Lett; 2014 Jul; 228(2):75-84. PubMed ID: 24769261
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression.
Hreiche R; Mégarbane B; Pirnay S; Borron SW; Monier C; Risède P; Milan N; Descatoire V; Pessayre D; Baud FJ
Toxicol Appl Pharmacol; 2006 Dec; 217(3):352-62. PubMed ID: 17084876
[TBL] [Abstract][Full Text] [Related]
6. Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
Tzatzarakis MN; Vakonaki E; Kovatsi L; Belivanis S; Mantsi M; Alegakis A; Liesivuori J; Tsatsakis AM
J Anal Toxicol; 2015 May; 39(4):313-20. PubMed ID: 25663675
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats.
Pirnay S; Megarbane B; Declèves X; Risède P; Borron SW; Bouchonnet S; Perrin B; Debray M; Milan N; Duarte T; Ricordel I; Baud FJ
Toxicol Sci; 2008 Nov; 106(1):64-73. PubMed ID: 18703559
[TBL] [Abstract][Full Text] [Related]
8. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
DiFrancesco R; Fischl MA; Donnelly J; Zingman BS; McCance-Katz EF; Moody DE; Reichman RC; Gripshover B; Morse GD
J Pharm Biomed Anal; 2007 May; 44(1):188-95. PubMed ID: 17391891
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.
Concheiro-Guisan M; Shakleya DM; Huestis MA
Anal Bioanal Chem; 2009 May; 394(2):513-22. PubMed ID: 19247639
[TBL] [Abstract][Full Text] [Related]
11. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.
Concheiro M; Jones HE; Johnson RE; Choo R; Huestis MA
Ther Drug Monit; 2011 Oct; 33(5):619-26. PubMed ID: 21860340
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma.
Murphy CM; Huestis MA
J Mass Spectrom; 2005 Jan; 40(1):70-4. PubMed ID: 15637731
[TBL] [Abstract][Full Text] [Related]
13. In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study.
Chan GN; Saldivia V; Yang Y; Pang H; de Lannoy I; Bendayan R
J Neurochem; 2013 Nov; 127(3):342-52. PubMed ID: 23777437
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.
Kacinko SL; Jones HE; Johnson RE; Choo RE; Concheiro-Guisan M; Huestis MA
Clin Chem; 2009 Jun; 55(6):1177-87. PubMed ID: 19325013
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.
Concheiro M; Shakleya DM; Huestis MA
Forensic Sci Int; 2009 Jul; 188(1-3):144-51. PubMed ID: 19406593
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists.
Smith BJ; Doran AC; McLean S; Tingley FD; O'Neill BT; Kajiji SM
J Pharmacol Exp Ther; 2001 Sep; 298(3):1252-9. PubMed ID: 11504828
[TBL] [Abstract][Full Text] [Related]
17. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Huang W; Moody DE; McCance-Katz EF
Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study.
Pirnay S; Bouchonnet S; Hervé F; Libong D; Milan N; D'Athis P; Baud F; Ricordel I
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):335-42. PubMed ID: 15203048
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage.
Skopp G; Kniest A; Haisser J; Mann K; Hermann D
Int J Legal Med; 2011 Mar; 125(2):277-81. PubMed ID: 21301858
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment.
Belivanis S; Tzatzarakis MN; Vakonaki E; Kovatsi L; Mantsi M; Alegakis A; Kavvalakis MP; Vynias D; Tsatsakis AM
Drug Test Anal; 2014 Jun; 6 Suppl 1():93-100. PubMed ID: 24817054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
